Sun.Apr 18, 2021

As plant/animal diversity wanes, is microbial life changing too? A perilously ‘profound Ignorance’

Scienmag

59

COVID-19 Brief: An Inhaled COVID-19 Vaccine, Expanded Antibody Access and Blood Clots

BioSpace

As the U.S. reports surges in COVID-19 infections despite increased enrollment in vaccines, news continues to break about therapies, vaccines, and the risks involved with the new vaccines. Here’s a look

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Common plants and pollinators act as anchors for ecosystems

Scienmag

Credit: Julian Resasco The next time you go for a hike, take an extra moment to appreciate the seemingly ordinary life all around you.

59

Bristol Myers’ Opdivo Receives FDA Approval for Gastric Cancer

BioSpace

Opdivo, the trade name for the generic Nivolumab, can now be used in combination with certain types of chemotherapy for initial treatment of advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma

Study aims to improve health of patients with CF across their increasing lifespan

Scienmag

Credit: Kim Ratliff, Augusta University People with cystic fibrosis are living better and longer, and now investigators want to further enhance quality and longevity by better understanding the role of nutrition, body composition and exercise in their health across an increasing lifespan.

Lyndra Therapeutics Presents Promising Phase 2 Data on Once-Weekly Oral Risperidone Treatment, LYN-005, in Development for Schizophrenia

BioTech 365

Adagio Raises $336 Million to Support Development of COVID-19 Antibody Candidate

BioSpace

The new financing round was led by RA Capital Management, in tandem with new investors Redmile Group, Federated Hermes, Foresite Capital, ArrowMark Partners, PremjiInvest, and another unnamed investor from the health care space

More Trending

Tonix Seeks to Advance OyaGen’s COVID-19 Treatment Under New Global Licensing Deal

BioSpace

The companies also plan to develop the candidate for the treatment of other potential future viral diseases

Under 30 and sexually active? It’s a good idea to get tested for chlamydia and gonorrhea

Scienmag

Canadian Task Force on Preventive Health Care recommends routine screening Anyone sexually active under age 30 should be offered testing for chlamydia and gonorrhea, according to a new guideline from the Canadian Task Force on Preventive Health Care published in CMAJ (Canadian Medical Association Journal). Chlamydia and gonorrhea are the most commonly reported sexually transmitted […].

Q&A with Acting FDA Commissioner Janet Woodcock on the Future of the FDA

BioSpace

Acting FDA Commissioner Janet Woodcock shared her thoughts on pandemic issues and outlined FDA modernization plans in a recent Q&A session with the Alliance for a Stronger FDA (Alliance

68

Online farmers’ markets valuable when crisis events like COVID occur

Scienmag

New research is shining light on the importance of farmers’ markets’ ability to mitigate potential disruptions to distribution networks in the face of system shocks like the COVID-19 pandemic New research is shining light on the importance of farmers’ markets’ ability to mitigate potential disruptions to distribution networks in the face of system shocks like […].

Anixa Hits FDA Speedbump for Ovarian Cancer CAR-T Trial Approval

BioSpace

The government agency is asking for more information before approving a clinical study on the company’s Chimeric Antigen Receptor-T cell therapy (CAR-T

European Commission approves second indication of Sarclisa® (isatuximab) for relapsed multiple myeloma

BioTech 365

European Commission approves second indication of Sarclisa® (isatuximab) for relapsed multiple myeloma European Commission approves second indication of Sarclisa® (isatuximab) for relapsed multiple myeloma European Commission approves second indication of Sarclisa® (isatuximab) for relapsed multiple myeloma Approval … Continue reading → GlobeNewswire

40

Lyndra Therapeutics' Once-Per-Week Schizophrenia Treatment Shines in Phase II

BioSpace

A Phase II schizophrenia treatment is showing promise for patients diagnosed with this complex and chronic brain disorder

63

NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF APRIL 1, 2021

BioTech 365

NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF APRIL 1, 2021 NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF APRIL 1, 2021 Marseille, France, April 19, 2021 (GLOBE NEWSWIRE) — Pursuant to the article … Continue reading → GlobeNewswire

40

Fauci Says J&J Vaccine Likely to Resume by Friday

BioSpace

The vaccine distribution has been paused in the country because of six or seven cases of rare blood clots

Number of Shares and Voting Rights of Innate Pharma as of April 1, 2021

BioTech 365

Number of Shares and Voting Rights of Innate Pharma as of April 1, 2021 Number of Shares and Voting Rights of Innate Pharma as of April 1, 2021 MARSEILLE, France, April 19, 2021 (GLOBE NEWSWIRE) — Pursuant to the article … Continue reading → GlobeNewswire

40

J&J, Teva and Other Opioid Drugmakers Face $50 Billion Lawsuit in California

BioSpace

Johnson & Johnson, Endo International, AbbVie’s Allergan unit and Teva Pharmaceutical will head to court this morning in California over claims the companies engaged in deceptive marketing practices that fueled the opioid crisis in America

Nyxoah Announces Submission of Draft Registration Statement For Proposed Public Listing in the United States

BioTech 365

Nyxoah Announces Submission of Draft Registration Statement For Proposed Public Listing in the United States Nyxoah Announces Submission of Draft Registration Statement For Proposed Public Listing in the United States REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Announces Submission of Draft Registration Statement … Continue reading → GlobeNewswire

Clinical Catch-Up: April 12-16

BioSpace

It was a particularly busy week for clinical trial news, in part because of several big medical conferences. Here’s a look

Relief Comments on Certain Statements Made by NeuroRx, Inc. in the Amended Form S-4 Filing of Big Rock Partners Acquisition Corp.

BioTech 365

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Miscellaneous 19.04.2021 / 07:00 Relief Comments on Certain Statements Made by NeuroRx, Inc. in the Amended Form S-4 Filing of Big Rock Partners Acquisition Corp. Geneva, Switzerland, April 19, 2021 – … Continue reading → EQS Newsfeed

40

Sponsored | Business Transformation during a Pandemic: Q&A about Jubilant Biosys’ bold plans wit.

BioSpace

This is by far the most exciting time in our history as Jubilant Biosys, and certainly the most exciting message Biosys has ever announced simply because of the sheer scale of transformation that we’ve taken on. It’s massive, very achievable, and ultimately truly transformative for us as colleagu

49

Cosmo announces the start of trading of its shares on XETRA

BioTech 365

Cosmo Pharmaceuticals N.V. / Key word(s): Miscellaneous 19-Apr-2021 / 06:00 GMT/BST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. Dublin, Ireland – 19 April 2021: Shares … Continue reading → EQS Newsfeed

40

Assessment of Methylene Chloride–Related Fatalities in the United States, 1980-2018

JAMA Internal Medicine

This case series analyzes characteristics of methylene chloride–related fatalities in the United States from 1980 to 2018

43

SYNLAB sets price range for its planned IPO at EUR 18.00 to EUR 23.00 per share

BioTech 365

DGAP-News: Synlab AG / Key word(s): IPO 19.04.2021 / 07:30 The issuer is solely responsible for the content of this announcement. SYNLAB AG Moosacher Straße 88 80809 Munich Germany Press release Munich, 19 April 2021 SYNLAB aims to raise … Continue reading → EQS Newsfeed

40

COVID – “Tell us the truth”

World of DTC Marketing

QUICK READ: According to the Times 89% of all media stories on COVID have been negative. While less tan 5% of people who get COVID will require hospitalization both Democrats and Republicans believe that number is a lot higher.

My Vaccine Program (MVP) Combines Best-of-Breed Technologies to Address Consumer Engagement, Vaccine Hesitancy and Safety Surveillance Related to COVID-19

BioTech 365

My Vaccine Program (MVP) Combines Best-of-Breed Technologies to Address Consumer Engagement, Vaccine Hesitancy and Safety Surveillance Related to COVID-19 My Vaccine Program (MVP) Combines Best-of-Breed Technologies to Address Consumer Engagement, Vaccine Hesitancy and Safety Surveillance Related to COVID-19 As COVID … Continue reading → Business Wire

Rethinking Routine Peripheral Intravenous Line Placement

JAMA Internal Medicine

This Teachable Moment considers the routine insertion of peripheral intravenous catheters in hospital patients given that the harms sometimes outweigh the benefits

40

Prothena Presents Phase 1 Study Results of PRX004 in Oral Presentation at AAN 2021

BioTech 365

Prothena Presents Phase 1 Study Results of PRX004 in Oral Presentation at AAN 2021 Prothena Presents Phase 1 Study Results of PRX004 in Oral Presentation at AAN 2021 Slowing of neuropathy progression for all 7 evaluable patients, evidenced by a … Continue reading → GlobeNewswire

40

Adverse Events Associated With the Addition of Aspirin to Direct Oral Anticoagulant Therapy

JAMA Internal Medicine

This cohort study evaluates whether dual therapy with acetylsalicylic acid and a therapeutically dosed direct oral anticoagulant increases rates of bleeding

40

Pixium Vision announces its cash position at 31 March 2021 and provides an update on its activities and financial outlook until the end of 2021.

BioTech 365

Pixium Vision announces its cash position at 31 March 2021 and provides an update on its activities and financial outlook until the end of 2021. Pixium Vision announces its cash position at 31 March 2021 and provides an update on … Continue reading → GlobeNewswire

40

Drug Patent Expirations for the Week of April 18, 2021

Drug Patent Watch

ZYDELIG (idelalisib) Gilead sciences inc Patent: 6,800,620 Expiration: Apr 24, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com…. The post Drug Patent Expirations for the Week of April 18, 2021 appeared first on DrugPatentWatch - Make Better Decisions. Patent Expiration

Drugs 40

Pharmaceutical companies with the most ‘New Patient Population’ drugs

Drug Patent Watch

This chart shows the companies which have received the most New Patient Population exclusivities in the past five years. New Patient Populations are one of the categories for which the…. The post Pharmaceutical companies with the most ‘New Patient Population’ drugs appeared first on DrugPatentWatch - Make Better Decisions. Infographic

Drugs 40